Reshma Rangwala
KPTIReshma Rangwala serves as officer: EVP & Chief Medical Officer at Karyopharm Therapeutics Inc. (KPTI). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.
Reshma Rangwala's Insider Trading at Karyopharm Therapeutics Inc. (KPTI)
Buys
0 · $0.00
Sells
6 · $110.8K
Total Shares Bought
0
Total Shares Sold
23,039
Related Insiders
Stuart Poulton
officer: EVP, Chief Development Officer
KPTISell · Mar 2, 2026
Sohanya Roshan Cheng
officer: EVP & Chief Commercial Officer
KPTISell · Mar 2, 2026
Michael Mano
officer: EVP, CLO&Secretary
KPTISell · Mar 2, 2026
Richard A. Paulson
director, officer: President and CEO
KPTISell · Mar 2, 2026
Stuart Poulton
EVP, Chief Development Officer
KPTISell · Feb 17, 2026
Lori Macomber
officer: EVP, CFO & Treasurer
KPTISell · Feb 3, 2026
Kristin Abate
officer: Chief Accounting Officer
KPTISell · Jan 28, 2026
Kristin Abate
Chief Accounting Officer
KPTISell · Oct 1, 2025